El tratamiento de la otitis media persistente.

EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.

Frontiers in allergy·2026

ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care.

Frontiers in allergy·2025

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Frontiers in allergy·2025

Pocket guide: biologics in upper and lower airways in adults.

Rhinology·2025

EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR.

Frontiers in allergy·2025

European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.

Frontiers in allergy·2024

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Towards generalizable contactless oximetry from multispectral video via deep domain-adaptive learning strategy.

Biomedical optics express·2026

Conductivity optimization of La0.3Sr0.7TiO3/La0.8Sr0.2MnO3 bilayer interconnects via interfacial oxygen partial pressure regulation and its application in FT-SIS-SOFCs.

Chemical science·2026

FBG-Based Multi-Parameter Sensor for Harsh Transformer Conditions: Decoupling Packaging for Simultaneous Temperature, Pressure, and Moisture Measurement.

Sensors (Basel, Switzerland)·2026

A Fast Demodulation Algorithm for Fibre Bragg Grating Based on the TimeMixer-LightGBM Hybrid Learning Framework.

Sensors (Basel, Switzerland)·2026

Distributed Wi-Fi-Based System for Monitoring the Condition of Building Structures.

Sensors (Basel, Switzerland)·2026

Coverage Probability Analysis and Relay Placement Optimization for Two-Hop LoRa Networks with Random Traffic Activation.

Sensors (Basel, Switzerland)·2026

Videos de Experimentos Relacionados

El tratamiento de la otitis media persistente

Videos de Conceptos Relacionados

EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.

ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care.

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Pocket guide: biologics in upper and lower airways in adults.

EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR.

European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Towards generalizable contactless oximetry from multispectral video via deep domain-adaptive learning strategy.

Conductivity optimization of La0.3Sr0.7TiO3/La0.8Sr0.2MnO3 bilayer interconnects via interfacial oxygen partial pressure regulation and its application in FT-SIS-SOFCs.

FBG-Based Multi-Parameter Sensor for Harsh Transformer Conditions: Decoupling Packaging for Simultaneous Temperature, Pressure, and Moisture Measurement.

A Fast Demodulation Algorithm for Fibre Bragg Grating Based on the TimeMixer-LightGBM Hybrid Learning Framework.

Distributed Wi-Fi-Based System for Monitoring the Condition of Building Structures.

Coverage Probability Analysis and Relay Placement Optimization for Two-Hop LoRa Networks with Random Traffic Activation.

Videos de Experimentos Relacionados

El tratamiento de la otitis media persistente

Videos de Conceptos Relacionados

Artículos Relacionados